These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 27127163

  • 21. Early thrombomodulin-α administration outcome for acute disseminated intravascular coagulopathy in gastrointestinal surgery.
    Konishi H, Okamoto K, Shoda K, Arita T, Kosuga T, Morimura R, Komatsu S, Murayama Y, Shiozaki A, Kuriu Y, Ikoma H, Nakanishi M, Ichikawa D, Fujiwara H, Otsuji E.
    World J Gastroenterol; 2017 Feb 07; 23(5):891-898. PubMed ID: 28223734
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of recombinant human soluble thrombomodulin in severe postpartum hemorrhage with disseminated intravascular coagulation.
    Sugawara J, Suenaga K, Hoshiai T, Sato T, Nishigori H, Nagase S, Yaegashi N.
    Clin Appl Thromb Hemost; 2013 Sep 07; 19(5):557-61. PubMed ID: 22496090
    [Abstract] [Full Text] [Related]

  • 23. A retrospective study on safety and efficacy of recombinant human soluble thrombomodulin to acute aortic dissection with disseminated intravascular coagulation.
    Ikeda T, Uchiyama M, Ozawa N, Imazuru T, Shimokawa T.
    J Cardiothorac Surg; 2024 Sep 11; 19(1):523. PubMed ID: 39261885
    [Abstract] [Full Text] [Related]

  • 24. The efficacy of recombinant human soluble thrombomodulin for obstetric disseminated intravascular coagulation: a retrospective study.
    Yoshihara M, Uno K, Tano S, Mayama M, Ukai M, Kondo S, Kokabu T, Kishigami Y, Oguchi H.
    Crit Care; 2015 Oct 20; 19():369. PubMed ID: 26481315
    [Abstract] [Full Text] [Related]

  • 25. Assessment of bleeding in patients with disseminated intravascular coagulation after receiving surgery and recombinant human soluble thrombomodulin: A cohort study using a database.
    Yamaguchi T, Kitajima Y, Miyauchi Y, Izawa K, Tanaka M, Hirata M, Sadatsuki Y, Ogawa Y.
    PLoS One; 2018 Oct 20; 13(10):e0205146. PubMed ID: 30296304
    [Abstract] [Full Text] [Related]

  • 26. [A case of esophageal cancer with septic disseminated intravascular coagulation treated with recombinant human soluble thrombomodulin during chemoradiation therapy].
    Sasaki K, Okumura H, Uchikado Y, Minami K, Ijichi T, Owaki T, Ishigami S, Natsugoe S.
    Gan To Kagaku Ryoho; 2013 Sep 20; 40(9):1213-5. PubMed ID: 24047782
    [Abstract] [Full Text] [Related]

  • 27. [Successful treatment using recombinant thrombomodulin for disseminated intravascular coagulation associated with recurrent prosthetic valve endocarditis].
    Masuda S, Adachi O, Ito K, Matsuo S, Hayatsu Y, Suzuki Y, Saito T, Akiyama M, Kumagai K, Motoyoshi N, Kawamoto S, Saiki Y.
    Kyobu Geka; 2013 Feb 20; 66(2):101-5. PubMed ID: 23381354
    [Abstract] [Full Text] [Related]

  • 28. Impact of recombinant soluble thrombomodulin (thrombomodulin alfa) on disseminated intravascular coagulation.
    Mimuro J, Takahashi H, Kitajima I, Tsuji H, Eguchi Y, Matsushita T, Kuroda T, Sakata Y.
    Thromb Res; 2013 May 20; 131(5):436-43. PubMed ID: 23566534
    [Abstract] [Full Text] [Related]

  • 29. Recombinant human soluble thrombomodulin safely and effectively rescues acute promyelocytic leukemia patients from disseminated intravascular coagulation.
    Ikezoe T, Takeuchi A, Isaka M, Arakawa Y, Iwabu N, Kin T, Anabuki K, Sakai M, Taniguchi A, Togitani K, Yokoyama A.
    Leuk Res; 2012 Nov 20; 36(11):1398-402. PubMed ID: 22917769
    [Abstract] [Full Text] [Related]

  • 30. [Successful treatment with recombinant thrombomodulin for disseminated intravascular coagulation complicated with hemophagocytic syndrome].
    Yamazaki H, Kondo T, Tatsumi G, Kotani S, Arai Y, Shirakawa K, Kitano T, Hishizawa M, Kadowaki N, Takaori-Kondo A.
    Rinsho Ketsueki; 2015 Mar 20; 56(3):312-6. PubMed ID: 25876785
    [Abstract] [Full Text] [Related]

  • 31. Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study.
    Hayakawa M, Yamakawa K, Saito S, Uchino S, Kudo D, Iizuka Y, Sanui M, Takimoto K, Mayumi T, Ono K, Japan Septic Disseminated Intravascular Coagulation (JSEPTIC DIC) study group.
    Thromb Haemost; 2016 Jun 02; 115(6):1157-66. PubMed ID: 26939575
    [Abstract] [Full Text] [Related]

  • 32. Effect of recombinant human soluble thrombomodulin on clinical outcomes of patients with coagulopathy after hematopoietic stem cell transplantation.
    Ikezoe T, Takeuchi A, Chi S, Takaoka M, Anabuki K, Kim T, Sakai M, Taniguchi A, Togitani K, Yokoyama A.
    Eur J Haematol; 2013 Nov 02; 91(5):442-7. PubMed ID: 23952647
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of the safety and efficacy of recombinant soluble thrombomodulin for patients with disseminated intravascular coagulation associated with acute leukemia: multicenter prospective study by the Tohoku Hematology Forum.
    Yokoyama H, Takahashi N, Katsuoka Y, Inomata M, Ito T, Meguro K, Kameoka Y, Tsumanuma R, Murai K, Noji H, Ishizawa K, Ito S, Onishi Y, Harigae H, Tohoku Hematology Forum.
    Int J Hematol; 2017 May 02; 105(5):606-613. PubMed ID: 28176226
    [Abstract] [Full Text] [Related]

  • 34. Recombinant human soluble thrombomodulin (thrombomodulin alfa) to treat disseminated intravascular coagulation in solid tumors: results of a one-arm prospective trial.
    Tamura K, Saito H, Asakura H, Okamoto K, Tagawa J, Hayakawa T, Aoki N.
    Int J Clin Oncol; 2015 Aug 02; 20(4):821-8. PubMed ID: 25385713
    [Abstract] [Full Text] [Related]

  • 35. Clinical Outcomes of Recombinant Human-soluble Thrombomodulin Treatment for Disseminated Intravascular Coagulation in Solid Tumors.
    Kashiwagi S, Asano Y, Takahashi K, Shibutani M, Amano R, Tomita S, Hirakawa K, Ohira M.
    Anticancer Res; 2019 May 02; 39(5):2259-2264. PubMed ID: 31092417
    [Abstract] [Full Text] [Related]

  • 36. Clinical features and treatment outcomes of six patients with disseminated intravascular coagulation resulting from acute promyelocytic leukemia and treated with recombinant human soluble thrombomodulin at a single institution.
    Kawano N, Kuriyama T, Yoshida S, Yamashita K, Ochiai H, Nakazaki S, Tasaki A, Ueda A.
    Intern Med; 2013 May 02; 52(1):55-62. PubMed ID: 23291674
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Recombinant Thrombomodulin in Disseminated Intravascular Coagulation Associated with Stage IV Solid Tumors: A Nationwide Observational Study in Japan.
    Taniguchi K, Ohbe H, Yamakawa K, Matsui H, Fushimi K, Yasunaga H.
    Thromb Haemost; 2021 Jan 02; 121(1):36-45. PubMed ID: 32906154
    [Abstract] [Full Text] [Related]

  • 40. Recombinant human thrombomodulin for pneumonia-induced severe ARDS complicated by DIC in children: a preliminary study.
    Hirata N, Ngo DT, Phan PH, Ainai A, Phung TTB, Ta TA, Takasaki J, Kawachi S, Nunoi H, Nakajima N, Dien TM.
    J Anesth; 2021 Oct 02; 35(5):638-645. PubMed ID: 34259911
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.